Skip to main content
Clinical Trials/EUCTR2011-002028-41-GB
EUCTR2011-002028-41-GB
Active, Not Recruiting
N/A

A study to determine regional lung function in patients with Non-small cell lung cancer (NSCLC) undegoing radiotherapy using hyperpolarised xenon gas MR imaging - Hyperpolarized xenon gas MR imaging in NSCLC Radiotherapy

Overview

Phase
N/A
Intervention
Not specified
Conditions
on-small cell lung cancer.
Sponsor
Oxford University Hospitals NHS Trust
Status
Active, Not Recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 4, 2014
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Study participants with any stage NSCLC considered suitable for radical radiotherapy (with either conventionally fractionated treatment or with stereotactic body radiotherapy (SABR)) or chemoradiotherapy (concurrent or sequential schedule) will be recruited.
  • Inclusion Criteria
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 years or above.
  • Histologically verified NSCLC.
  • Patients with any stage NSCLC where radical radiotherapy (with either conventionally fractionated treatment or with stereotactic body radiotherapy (SABR)) or chemoradiotherapy (concurrent or sequential schedule) is considered appropriate.
  • WHO performance status 0\-2
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0

Exclusion Criteria

  • Exclusion Criteria
  • The participant may not enter the study if ANY of the following apply:
  • Inability to give written informed consent.
  • Female participants who are pregnant, lactating or planning pregnancy
  • during the course of the trial
  • Previous radiotherapy to the chest.
  • The presence of another condition where the disease itself or treatment may interfere with the study endpoints.
  • Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule.
  • Inability to lie flat for imaging.
  • Contraindications to MRI examination including indwelling pacemaker, non\-MRI compatible metallic implant, severe claustrophobia, intra\-ocular foreign body.

Outcomes

Primary Outcomes

Not specified

Similar Trials